SCHEMBL4229661

SCHEMBL4229661

OC(c1ccc2ccccc2n1)C(c1ccccc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
HSD17B10 Q99714 1/20 0.45
S1PR3 Q99500 1/20 0.44
KDM4E B2RXH2 4/20 0.42
LMNA P02545 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HPGD P15428 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
MGAM O43451 1/20 0.42
PRNP P04156 1/20 0.41
MAPK10 P53779 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
ADORA2A P29274 1/20 0.40
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
CNR2 P34972 1/20 0.39
NCF1 P14598 2/20 0.38
NOS2 P35228 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2028207 0.78 S1PR3 (0.47) ALDH1A1HSD17B10S1PR3KDM4ELMNA
SCHEMBL4138519 0.78 ALDH1A1 (0.51) ALDH1A1HSD17B10KDM4ELMNASMN1; SMN2
SCHEMBL7461862 0.77 ALDH1A1 (0.50) ALDH1A1HSD17B10S1PR3KDM4ELMNA
SCHEMBL12915380 0.77 S1PR3 (0.49) ALDH1A1HSD17B10S1PR3KDM4ELMNA
SCHEMBL10020390 0.77 ALDH1A1 (0.53) ALDH1A1HSD17B10S1PR3KDM4ELMNA
SCHEMBL7469957 0.74 S1PR3 (0.47) ALDH1A1HSD17B10S1PR3KDM4ELMNA
SCHEMBL11732619 0.74 S1PR3 (0.47) ALDH1A1HSD17B10S1PR3KDM4ELMNA
SCHEMBL9094486 0.74 S1PR3 (0.47) ALDH1A1HSD17B10S1PR3KDM4ELMNA
SCHEMBL28818196 0.74 S1PR3 (0.47) ALDH1A1HSD17B10S1PR3KDM4ELMNA
SCHEMBL4289764 0.74 MGAM (0.49) ALDH1A1HSD17B10S1PR3KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009024095-A1 METHOD OF MAKING AND ADMINISTERING QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS THE HONG KONG POLYTECHNIC UNIVERSITY (CN) 2009-02-26 WO disclosed